DJ Back

1.8k total citations
49 papers, 1.5k citations indexed

About

DJ Back is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, DJ Back has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 17 papers in Pediatrics, Perinatology and Child Health and 13 papers in Pharmacology. Recurrent topics in DJ Back's work include HIV/AIDS drug development and treatment (22 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Pharmacogenetics and Drug Metabolism (12 papers). DJ Back is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Pharmacogenetics and Drug Metabolism (12 papers). DJ Back collaborates with scholars based in United Kingdom, Ireland and Italy. DJ Back's co-authors include AM Breckenridge, ML Orme, M. Orme, J. Tjia, BK Park, J Karbwang, J.L. Maggs, D Chadwick, Pamela Crawford and Carmen Martín and has published in prestigious journals such as British Journal of Pharmacology, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

DJ Back

49 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DJ Back United Kingdom 24 586 415 354 347 313 49 1.5k
D.J. Back United Kingdom 29 615 1.0× 475 1.1× 388 1.1× 596 1.7× 629 2.0× 80 2.2k
Klaus‐Dieter Riedel Germany 22 363 0.6× 278 0.7× 293 0.8× 488 1.4× 179 0.6× 36 1.5k
Juan J.L. Lertora United States 24 210 0.4× 252 0.6× 185 0.5× 399 1.1× 156 0.5× 49 1.7k
Manoli Vourvahis United States 21 334 0.6× 277 0.7× 444 1.3× 502 1.4× 90 0.3× 55 1.4k
Farkad Ezzet Switzerland 19 387 0.7× 151 0.4× 186 0.5× 381 1.1× 748 2.4× 27 1.7k
Lisa M. Almond United Kingdom 17 327 0.6× 259 0.6× 324 0.9× 381 1.1× 79 0.3× 34 1.1k
René Verbesselt Belgium 28 344 0.6× 787 1.9× 441 1.2× 197 0.6× 217 0.7× 95 2.3k
E Singlas France 23 198 0.3× 299 0.7× 235 0.7× 355 1.0× 62 0.2× 86 1.4k
Kevin T. Batty Australia 25 451 0.8× 242 0.6× 215 0.6× 331 1.0× 1.2k 3.8× 102 2.2k
Huy Riêm Ha Switzerland 16 504 0.9× 249 0.6× 482 1.4× 258 0.7× 43 0.1× 21 1.3k

Countries citing papers authored by DJ Back

Since Specialization
Citations

This map shows the geographic impact of DJ Back's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DJ Back with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DJ Back more than expected).

Fields of papers citing papers by DJ Back

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DJ Back. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DJ Back. The network helps show where DJ Back may publish in the future.

Co-authorship network of co-authors of DJ Back

This figure shows the co-authorship network connecting the top 25 collaborators of DJ Back. A scholar is included among the top collaborators of DJ Back based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DJ Back. DJ Back is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lambert, John S., Valerie Jackson, Sara Gibbons, et al.. (2010). Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy. HIV Medicine. 12(3). 166–173. 31 indexed citations
2.
Dickinson, Laura, Akil Jackson, Victoria Watson, et al.. (2010). Population pharmacokinetic modelling of once‐daily ritonavir‐boosted darunavir in HIV‐infected patients. Journal of the International AIDS Society. 13(S4). 7 indexed citations
3.
Lamba, H, et al.. (2010). The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers. Journal of the International AIDS Society. 13(S4). 4 indexed citations
4.
Back, DJ. (2010). HIV therapy in an ageing population — the challenge of polypharmacy. Journal of the International AIDS Society. 13(S4). 1 indexed citations
5.
Jackson, Valerie, et al.. (2010). Therapeutic drug monitoring (TDM) of atazanavir in pregnancy. Journal of the International AIDS Society. 13(S4). 3 indexed citations
6.
Nair, D.R., Colette Smith, Deirdre Egan, et al.. (2009). The Relationships of ABCB1 3435C>T and CYP2B6 516G>T With High-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Efavirenz. Clinical Pharmacology & Therapeutics. 86(2). 204–211. 8 indexed citations
7.
Liptrott, Neill J., Melissa A. Penny, Jean G. Sathish, et al.. (2009). The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. British Journal of Pharmacology. 156(3). 497–508. 63 indexed citations
8.
9.
Back, DJ, et al.. (2000). Current uses and future hopes for clinical pharmacology in the management of HIV infection. HIV Medicine. 1(s2). 12–17. 3 indexed citations
10.
Barry, Michael, et al.. (1994). Zidovudine pharmacokinetics in zidovudine‐induced bone marrow toxicity.. British Journal of Clinical Pharmacology. 37(1). 7–12. 18 indexed citations
11.
Barry, Michael, DJ Back, AM Breckenridge, et al.. (1994). Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.. British Journal of Clinical Pharmacology. 37(5). 421–426. 23 indexed citations
12.
Back, DJ, et al.. (1992). Cyclosporin metabolism by human gastrointestinal mucosal microsomes.. British Journal of Clinical Pharmacology. 33(6). 661–664. 41 indexed citations
13.
Back, DJ, et al.. (1990). Azoles and allylamines: the clinical implications of interaction with cytochrome P-450 enzymes. Journal of Dermatological Treatment. 1(sup2). 11–13. 18 indexed citations
14.
Karbwang, J, et al.. (1988). Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women.. PubMed. 66(6). 763–7. 12 indexed citations
15.
Back, DJ, et al.. (1988). In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.. British Journal of Clinical Pharmacology. 26(1). 23–29. 100 indexed citations
16.
Winstanley, PA, et al.. (1985). Lack of effect of highly purified subunit influenza vaccination on theophylline metabolism.. British Journal of Clinical Pharmacology. 20(1). 47–53. 9 indexed citations
17.
Back, DJ, et al.. (1984). 2‐Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine.. British Journal of Clinical Pharmacology. 18(4). 603–607. 18 indexed citations
18.
Back, DJ, et al.. (1982). The gut wall metabolism of ethinyloestradiol and its contribution to the pre‐systemic metabolism of ethinyloestradiol in humans.. British Journal of Clinical Pharmacology. 13(3). 325–330. 58 indexed citations
19.
Back, DJ, AM Breckenridge, M Bruce MacIver, et al.. (1980). The effect of oral contraceptive steroids and enzyme inducing drugs on sex hormone binding globulin capacity in women [proceedings]. British Journal of Clinical Pharmacology. 9(1). 115P–115P. 15 indexed citations
20.
Back, DJ, Mark C. Bates, AM Breckenridge, et al.. (1979). Plasma Xa inhibitory activities and plasma concentrations of norgestrel and ethinyloestradiol in women on oral contraceptive steroids.. British Journal of Clinical Pharmacology. 8(5). 505–506. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D.J. Back Breakdown of academic impact, for papers by Klaus‐Dieter Riedel Breakdown of academic impact, for papers by Juan J.L. Lertora Breakdown of academic impact, for papers by Manoli Vourvahis Breakdown of academic impact, for papers by Farkad Ezzet Breakdown of academic impact, for papers by Lisa M. Almond Breakdown of academic impact, for papers by René Verbesselt Breakdown of academic impact, for papers by E Singlas Breakdown of academic impact, for papers by Kevin T. Batty Breakdown of academic impact, for papers by Huy Riêm Ha
Rankless by CCL
2026